| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 20,730 | 20,740 | 10:20 | |
| 20,720 | 20,750 | 10:20 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08:00 | CVC Advisers Limited - Offer Update | ||
| Fr | CVC looking for partners for potential ITV takeover - report | ||
| Mi | CVC Capital eyes Vivendi's stake in Telecom Italia | ||
| Di | CVC eyes Vivendi's Telecom Italia stake | ||
| Di | dpa-AFX-Überblick: UNTERNEHMEN vom 17.12.2024 - 15.15 Uhr | ROUNDUP: Thyssenkrupp Nucera blickt eher verhalten auf neues Geschäftsjahr DORTMUND - Der Elektrolysespezialist Thyssenkrupp Nucera zeigt sich für das neue Geschäftsjahr 2024/25 (per Ende September)... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.12. | Mallinckrodt plc - 8-K, Current Report | ||
| 02.12. | CVC Completes Acquisition of Therakos from Mallinckrodt | CVC, a leading global private markets manager, today completed the previously announced acquisition of the Therakos business from Mallinckrodt plc ("Mallinckrodt"), a global specialty pharmaceutical... ► Artikel lesen | |
| 18.11. | Mallinckrodt reports on HRS treatment study | ||
| 14.11. | Mallinckrodt plc: Mallinckrodt announces the 2024 Winner of the Extracorporeal Immunomodulation Award | This year's award marks 30 years since clinicians first used ECP to successfully treat chronic graft versus host disease (cGvHD).1 In recognition of this important milestone, this year's... ► Artikel lesen | |
| 05.11. | Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance | Achieves Third Quarter Net Sales of $505.5 Million, Reflecting 1.7% Year-Over-Year Growth
Reaffirms Full Year Net Sales Guidance and Raises Full Year Adjusted EBITDA... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| CVC CAPITAL PARTNERS PLC | 20,760 | -0,95 % |
| MALLINCKRODT PLC | - | - |
